Cognitive Neurorehabilitation of HIV-associated Neurocognitive Disorders: A Qualitative Review and Call to Action

被引:41
作者
Weber, Erica [1 ,2 ,3 ]
Blackstone, Kaitlin [1 ,2 ,3 ]
Woods, Steven Paul [3 ,4 ]
机构
[1] San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Dept Psychiat 8231, HIV Neurobehav Res Program, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
HIV; AIDS dementia complex; Cognition; Cognitive rehabilitation; HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; COMBINATION ANTIRETROVIRAL THERAPY; MULTICENTER AIDS COHORT; PROSPECTIVE MEMORY; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL IMPAIRMENT; VERBAL FLUENCY;
D O I
10.1007/s11065-013-9225-6
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Despite significant advances in the virologic management of HIV infection over the last two decades, effective treatments for HIV-associated neurocognitive disorders (HAND) remain elusive. While pharmacological interventions have yielded some success in improving neurocognitive outcomes in HIV, there is a dearth of rigorous studies examining the efficacy of cognitive rehabilitation for remediating HIV-associated neurocognitive impairment. This qualitative review summarizes and critiques the emerging literature on cognitive and behavioral treatments for HAND, which provides many reasons for optimism, but also has major limitations that underscore the scope of the work that lies ahead. Considering the notable real-world consequences of HAND, the development, validation, and clinical deployment of cognitive neurorehabilitation interventions tailored to the needs of persons living with HIV infection is a priority for clinical neuroAIDS investigators. In describing potential future directions for this endeavor, particular attention was paid to the application of cognitive neuropsychological principles in developing theory-driven approaches to managing HAND, improving everyday functioning, and enhancing HIV health outcomes.
引用
收藏
页码:81 / 98
页数:18
相关论文
共 136 条
  • [1] Does Antiretroviral Therapy Improve HIV-Associated Cognitive Impairment? A Quantitative Review of the Literature
    Al-Khindi, Timour
    Zakzanis, Konstantine K.
    van Gorp, Wilfred G.
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2011, 17 (06) : 956 - 969
  • [2] Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders
    Ances, Beau M.
    Letendre, Scott L.
    Alexander, Terry
    Ellis, Ronald J.
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2008, 20 (01) : 89 - 93
  • [3] Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis
    Anderson, ER
    Gendelman, HE
    Xiong, HG
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (32) : 7194 - 7198
  • [4] A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment
    Andrade, ASA
    McGruder, HF
    Wu, AW
    Celano, SA
    Skolasky, RL
    Selnes, OA
    Huang, IC
    McArthur, JC
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (06) : 875 - 882
  • [5] [Anonymous], GUID US ANT AG HIV 1
  • [6] [Anonymous], 1995, ASSESSMENT, V2, P151, DOI DOI 10.1177/107319119500200205
  • [7] Updated research nosology for HIV-associated neurocognitive disorders
    Antinori, A.
    Arendt, G.
    Becker, J. T.
    Brew, B. J.
    Byrd, D. A.
    Cherner, M.
    Clifford, D. B.
    Cinque, P.
    Epstein, L. G.
    Goodkin, K.
    Gisslen, M.
    Grant, I.
    Heaton, R. K.
    Joseph, J.
    Marder, K.
    Marra, C. M.
    McArthur, J. C.
    Nunn, M.
    Price, R. W.
    Pulliam, L.
    Robertson, K. R.
    Sacktor, N.
    Valcour, V.
    Wojna, V. E.
    [J]. NEUROLOGY, 2007, 69 (18) : 1789 - 1799
  • [8] Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring
    Arnsten, JH
    Demas, PA
    Farzadegan, H
    Grant, RW
    Gourevitch, MN
    Chang, CJ
    Buono, D
    Eckholdt, H
    Howard, AA
    Schoenbaum, EE
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1417 - 1423
  • [9] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
    Bangsberg, DR
    Hecht, FM
    Charlebois, ED
    Zolopa, AR
    Holodniy, M
    Sheiner, L
    Bamberger, JD
    Chesney, MA
    Moss, A
    [J]. AIDS, 2000, 14 (04) : 357 - 366
  • [10] Bangsberg DR, 2001, J ACQ IMMUN DEF SYND, V26, P435, DOI 10.1097/00126334-200104150-00005